SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

50,865.93 926.15
(1.85%)

Dow Jones

7,414.60 126.61
(1.74%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,316.43 61.62
(0.60%)

Forex

USD-INR

95.34 -0.07
(-0.08%)

EUR-INR

110.08 -0.10
(-0.09%)

GBP-INR

127.59 -0.01
(-0.01%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Supriya Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543434

INE07RO01027

148.8189477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUPRIYA

35.96

7534.4

EPS(TTM)

Face Value()

Div & Yield %

26.03

0.11

Back

Ajanta Pharma's Paithan unit concludes USFDA inspection

Apr 22,2026

Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.

75,527.95 1,695.40 ( 2.30%)

50,865.93 926.15 (1.85%)

7,414.60 126.61 (1.74%)

66,063.56 1,846.29 (2.88%)

10,316.43 61.62 (0.60%)

95.34 -0.07 (-0.08%)

110.08 -0.10 (-0.09%)

127.59 -0.01 (-0.01%)

0.59 0.00 (-0.20%)